Analystreport

Unum Therapeutics Inc (NASDAQ: UMRX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

UNUM THERAPEUTICS INC COMMON  (UMRX) 
Last unum therapeutics inc common earnings: 3/26 07:30 am Check Earnings Report